Differences in the tumor biology and somatic mutations could be influenced by the ethnicity of the patients; a higher frequency of TP53, ARID1A, ERBB3, and CDKN1A mutations have been reported for white patients compared to non-white patients [17]. This evidence concerns the gene ARID1A and neoplasm.